Teva Pharmaceutical reported 240M in Interest Expense on Debt for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Aspen Pharmacare APN:SJ 514M 230M
Guangzhou Baiy 600332:CH 83.05M 6.31M
Kalbe Farma Tbk Pt KLBF:IJ 11.55B 1.93B
Richter Gedeon RICHT:HB 167M 22M
Sh Fosun Pharma 600196:CH CH 205.04M 38.65M
Teva Pharmaceutical TEVA:IT 240M 1000K